IR@PKUHSC  > 北京大学药学院  > 药剂学系
学科主题药学
Nanoscale Drug Delivery Platforms Overcome Platinum-Based Resistance in Cancer Cells Due to Abnormal Membrane Protein Trafficking
Xue, Xue1,2; Hall, Matthew D.3; Zhang, Qiang2; Wang, Paul C.4; Gottesman, Michael M.3; Liang, Xing-Jie1
关键词cancer cisplatin drug resistance nanoscale drug delivery platforms membrane trafficking nanotechnology chemotherapy abnormal membrane proteins
刊名ACS NANO
2013-12-01
DOI10.1021/nn405004f
7期:12页:10452-10464
收录类别SCI
文章类型Review
WOS标题词Science & Technology
类目[WOS]Chemistry, Multidisciplinary ; Chemistry, Physical ; Nanoscience & Nanotechnology ; Materials Science, Multidisciplinary
研究领域[WOS]Chemistry ; Science & Technology - Other Topics ; Materials Science
关键词[WOS]PLGA-PEG NANOPARTICLES ; DNA-DAMAGING AGENTS ; CISPLATIN-RESISTANCE ; MULTIDRUG-RESISTANCE ; COPPER TRANSPORTER ; TUMOR-CELLS ; PT(IV) PRODRUG ; P-GLYCOPROTEIN ; BREAST-CANCER ; LUNG-CANCER
英文摘要

The development of cellular resistance to platinum-based chemotherapies is often associated with reduced intracellular platinum concentrations. In some models, this reduction is due to abnormal membrane protein trafficking, resulting in reduced uptake by transporters at the cell surface. Given the central role of platinum drugs in the clinic, it is critical to overcome cisplatin resistance by bypassing the plasma membrane barrier to significantly increase the intracellular cisplatin concentration enough to inhibit the proliferation of cisplatin-resistant cells. Therefore, rational design of appropriate nanoscale drug delivery platforms (nDDPs) loaded with cisplatin or other platinum analogues as payloads is a possible strategy to solve this problem. This review will focus on the known mechanism of membrane trafficking in cisplatin-resistant cells and the development and employment of nDDPs to improve cell uptake of cisplatin.

语种英语
WOS记录号WOS:000329137100004
项目编号31225009 ; 2012BAF13B05 ; 81171455 ; 2009CB930200
资助机构National Natural Science Foundation for Distinguished Young Scholars of China ; National Science and Technology support program ; National Natural Science Foundation of China ; National Key Basic Research Program of China ; Chinese Academy of Sciences (CAS) "Hundred Talents Program" ; Intramural Research Program of the National Institutes of Health, National Cancer Institute
引用统计
被引频次:41[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/64801
专题北京大学药学院_药剂学系
作者单位1.Natl Ctr Nanosci & Technol China, CAS Key Lab Biomed Effects Nanomat & Nanosafety, Beijing 100190, Peoples R China
2.Peking Univ, Sch Pharmaceut Sci, Dept Pharmaceut, Beijing 100191, Peoples R China
3.NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
4.Howard Univ, Dept Radiol, Mol Imaging Lab, Washington, DC 20060 USA
推荐引用方式
GB/T 7714
Xue, Xue,Hall, Matthew D.,Zhang, Qiang,et al. Nanoscale Drug Delivery Platforms Overcome Platinum-Based Resistance in Cancer Cells Due to Abnormal Membrane Protein Trafficking[J]. ACS NANO,2013,7(12):10452-10464.
APA Xue, Xue,Hall, Matthew D.,Zhang, Qiang,Wang, Paul C.,Gottesman, Michael M.,&Liang, Xing-Jie.(2013).Nanoscale Drug Delivery Platforms Overcome Platinum-Based Resistance in Cancer Cells Due to Abnormal Membrane Protein Trafficking.ACS NANO,7(12),10452-10464.
MLA Xue, Xue,et al."Nanoscale Drug Delivery Platforms Overcome Platinum-Based Resistance in Cancer Cells Due to Abnormal Membrane Protein Trafficking".ACS NANO 7.12(2013):10452-10464.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xue, Xue]的文章
[Hall, Matthew D.]的文章
[Zhang, Qiang]的文章
百度学术
百度学术中相似的文章
[Xue, Xue]的文章
[Hall, Matthew D.]的文章
[Zhang, Qiang]的文章
必应学术
必应学术中相似的文章
[Xue, Xue]的文章
[Hall, Matthew D.]的文章
[Zhang, Qiang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。